Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Nat Med. 2013 Nov;19(11):1423-37. doi: 10.1038/nm.3394.
Cancers develop in complex tissue environments, which they depend on for sustained growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor microenvironment (TME) are genetically stable and thus represent an attractive therapeutic target with reduced risk of resistance and tumor recurrence. However, specifically disrupting the pro-tumorigenic TME is a challenging undertaking, as the TME has diverse capacities to induce both beneficial and adverse consequences for tumorigenesis. Furthermore, many studies have shown that the microenvironment is capable of normalizing tumor cells, suggesting that re-education of stromal cells, rather than targeted ablation per se, may be an effective strategy for treating cancer. Here we discuss the paradoxical roles of the TME during specific stages of cancer progression and metastasis, as well as recent therapeutic attempts to re-educate stromal cells within the TME to have anti-tumorigenic effects.
癌症是在复杂的组织环境中发展的,它们依赖于这种环境来持续生长、侵袭和转移。与肿瘤细胞不同,肿瘤微环境(TME)中的基质细胞类型在遗传上是稳定的,因此是一个有吸引力的治疗靶点,其耐药性和肿瘤复发的风险较低。然而,特异性地破坏促肿瘤微环境是一项具有挑战性的任务,因为微环境具有多种能力,可以诱导肿瘤发生的有益和不利后果。此外,许多研究表明,微环境能够使肿瘤细胞正常化,这表明对基质细胞进行重新教育,而不是单纯的靶向消融,可能是治疗癌症的有效策略。在这里,我们讨论了 TME 在癌症进展和转移的特定阶段中的矛盾作用,以及最近尝试重新教育 TME 中的基质细胞以产生抗肿瘤作用的治疗方法。